Faculty of Sciences, Department of Chemistry, University of Kragujevac, Kragujevac, Serbia.
Bioorg Med Chem Lett. 2011 Aug 1;21(15):4416-21. doi: 10.1016/j.bmcl.2011.06.025. Epub 2011 Jun 16.
Twenty five 4-aminomethylidene derivatives obtained from 3-phenyl-2-pyrazolin-5-one and 1,3-diphenyl-2-pyrazolin-5-one were synthesized and tested for their antiproliferative activity against human breast cancer MDA-MB-361 and MDA-MB-453 cell lines. The compounds derived from 1,3-diphenyl-2-pyrazolin-5-one exhibited the most remarkable activity in the treatment of both cell lines. In vitro antiproliferative activities were accompanied by an important apoptotic fraction of both cell lines; also, compounds inhibited key endothelial cell functions implicated in invasion and angiogenesis. QSAR methods were performed in order to analyze the influence of structural features of the compounds investigated on the antiproliferative potential on MDA-MB-361 and MDA-MB-453 cancer cells. One-parameter heuristic analysis was performed and different whole molecule and fragmental descriptors were considered for rationalization of mechanism of interaction of these compounds with active place of hypothetical target included in tumorigenesis.
合成了 25 种 3-苯基-2-吡唑啉-5-酮和 1,3-二苯基-2-吡唑啉-5-酮的 4-亚甲基衍生物,并测试了它们对人乳腺癌 MDA-MB-361 和 MDA-MB-453 细胞系的抗增殖活性。 源自 1,3-二苯基-2-吡唑啉-5-酮的化合物在治疗这两种细胞系方面表现出最显著的活性。 体外抗增殖活性伴随着两种细胞系的重要凋亡分数; 此外,化合物还抑制了参与侵袭和血管生成的关键内皮细胞功能。 为了分析所研究化合物的结构特征对 MDA-MB-361 和 MDA-MB-453 癌细胞增殖潜力的影响,进行了 QSAR 方法。 进行了单参数启发式分析,并考虑了不同的整体分子和片段描述符,以合理化这些化合物与包含在肿瘤发生中的假设靶标活性部位相互作用的机制。